Test Overview
Test Methodology

Enzyme-Linked Immunosorbent Assay (ELISA)

Test Usage

Diagnosis of recent infection with Bordetella pertussis in patients with > or = 2 weeks of symptoms consistent with whooping cough.

Reference Range *

<40 IU/mL (Negative); 40- <100 IU/mL (Borderline); > or = 100 IU/mL (Positive)

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Limitations

Immune response following vaccination cannot be distinguished from recent infection. For diagnosis, clinical symptoms, the age and the vaccination history of the patient should always be taken into account alongside results by this assay. Whooping cough caused by Bordetella parapertussis will not be detected by this assay. The CDC recommends nucleic acid amplification tests (NAAT) or culture as first-line tests for Bordetella pertussis infection. However, serologic testing may be useful in patients showing symptoms for >2 weeks.

Test Details
Days Set Up
Thursday
Analytic Time

2 - 9 days

Soft Order Code
BORDG
MiChart Code
Bordetella Pertussis Ab, IgG
Synonyms
  • Whooping Cough Antibody
  • Pertussis Antibody
  • LCBP
  • BORDAM
  • BORDGM
  • FBPERT
  • B. pertussis IgG Antibodies
  • DTAP Vaccine Response
Laboratory
Sendout
Reference Laboratory
Mayo BORDG
Section
Special Testing
Specimen Requirements
Collection Instructions

Collect specimen in an SST or red top tube. Centrifuge, aliquot serum into a plastic vial and refrigerate. Post-vaccination samples should be collected 4-6 weeks from the date of vaccination.

Normal Volume
1 mL serum
Minimum Volume
0.5 mL serum
Storage Temperature
Refrigerated preferred, frozen acceptable
Additional Information

Test is sent to Mayo Clinic Laboratories.

Billing
CPT Code
86615
Fee Code
20487
LOINC
29659-0